• ABOUT US
    ▼
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    ▼
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    ▼
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    ▼
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    ▼
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Visterra

We Bring Better Biologics to Life

  • ABOUT US
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Publications

Publications

Featured publications

Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study

March 7, 2020 | Antiviral Research
Susan E Sloan et al.

Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study

Susan E Sloan, Kristy J Szretter, Bharathi Sundaresh, Kristin M Narayan, Patrick F Smith, David Skurnik, Sylvain Bedard, José M Trevejo, David Oldach, Zachary Shriver

>READ

Quantifying the nativeness of antibody sequences using long short-term memory networks

December 31, 2019 | Protein Engineering, Design, and Selection
Andrew M Wollacott et al.

Quantifying the nativeness of antibody sequences using long short-term memory networks

Andrew M Wollacott, Chonghua Xue, Qiuyuan Qin, June Hua, Tanggis Bohnuud, Karthik Viswanathan, Vijaya B Kolachalama

>READ

A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy

March 16, 2019 | Kidney International
James R Myette et al.

A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy

James R Myette, Toshiki Kano, Hitoshi Suzuki, Susan E Sloan, Kristy J Szretter, Boopathy Ramakrishnan, Hedy Adari, Ketan D Deotale, Frank Engler, Zachary Shriver, Andrew M Wollacott, Yusuke Suzuki, Brian J G Pereira

>READ

Amino acid interaction networks provide a new lens for therapeutic antibody discovery and anti-viral drug optimization.

April 11, 2015 | Current Opinion in Virology
Karthik Viswanathan et al.

Amino acid interaction networks provide a new lens for therapeutic antibody discovery and anti-viral drug optimization.

Karthik Viswanathan, Zachary Shriver, Gregory J Babcock

>READ

Structural determinants for naturally evolving H5N1 hemagglutinin to switch its receptor specificity.

June 20, 2013 | Cell
Kannan Tharakaraman et al.

Structural determinants for naturally evolving H5N1 hemagglutinin to switch its receptor specificity.

Kannan Tharakaraman, Rahul Raman, Karthik Viswanathan, Nathan W Stebbins, Akila Jayaraman, Arvind Krishnan, V Sasisekharan, Ram Sasisekharan

>READ

Glycan receptor binding of the influenza A virus H7N9 hemagglutinin.

June 6, 2013 | Cell
Kannan Tharakaraman et al.

Glycan receptor binding of the influenza A virus H7N9 hemagglutinin.

Kannan Tharakaraman, Akila Jayaraman, Rahul Raman, Karthik Viswanathan, Nathan W Stebbins, David Johnson, Zachary Shriver, V Sasisekharan, Ram Sasisekharan

>READ

Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles.

May 22, 2013 | Virus Research
Charlermchai Artpradit et al.

Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles.

Charlermchai Artpradit, Luke N Robinson, Boris K Gavrilov, Troy T Rurak, Mathuros Ruchirawat, Ram Sasisekharan

>READ

Quantitative characterization of glycan-receptor binding of H9N2 influenza A virus hemagglutinin.

April 23, 2013 | PLoS One
Karunya Srinivasan et al.

Quantitative characterization of glycan-receptor binding of H9N2 influenza A virus hemagglutinin.

Karunya Srinivasan, Rahul Raman, Akila Jayaraman, Karthik Viswanathan, Ram Sasisekharan

>READ

Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic.

April 23, 2013 | PLoS One
Karunya Srinivasan et al.

Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic.

Karunya Srinivasan, Rahul Raman, Akila Jayaraman, Karthik Viswanathan, Ram Sasisekharan

>READ

Modular glycosphere assays for high-throughput functional characterization of influenza viruses.

April 15, 2013 | BMC Biotechnology
Sven N Hobbie et al.

Modular glycosphere assays for high-throughput functional characterization of influenza viruses.

Sven N Hobbie, Karthik Viswanathan, Ido Bachelet, Udayanath Aich, Zachary Shriver, Vidya Subramanian, Rahul Raman, Ram Sasisekharan

>READ

Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency.

April 8, 2013 | Proceedings of the National Academy of Sciences of the United States of America
Kannan Tharakaraman et al.

Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency.

Kannan Tharakaraman, Luke N Robinson, Andrew Hatas, Yi-Ling Chen, Liu Siyue, S Raguram, V Sasisekharan, Gerald N Wogan, Ram Sasisekharan

>READ

Quantitative description of glycan-receptor binding of influenza A virus H7 hemagglutinin.

February 20, 2013 | PloS One
Karunya Srinivasan et al.

Quantitative description of glycan-receptor binding of influenza A virus H7 hemagglutinin.

Karunya Srinivasan, Rahul Raman, Akila Jayaraman, Karthik Viswanathan, Ram Sasisekharan

>READ

Glycosylation at Asn91 of H1N1 haemagglutinin affects binding to glycan receptors.

December 19, 2011 | Scientific Reports
Venkataramanan Soundararajan et al.

Glycosylation at Asn91 of H1N1 haemagglutinin affects binding to glycan receptors.

Venkataramanan Soundararajan, Shu Zheng, Neel Patel, Ken Warnock, Rahul Raman, Ian A Wilson, S Raguram, V Sasisekharan, Ram Sasisekharan

>READ
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

© 2023 Visterra, Inc. Terms of usePrivacy PolicySite Design: Fassino/Design